Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.

Autor: Baden D; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel. david.baden@uksh.de., Zukunft S; Medical Department I, University Hospital of TU Dresden, Dresden., Hernandez G; TriNetX, TriNetX Europe NV, Sint-Martens-Latem., Wolgast N; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel., Steinhauser S; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel., Pohlmann A; Department of Medicine A, University Hospital Munster., Schliemann C; Department of Medicine A, University Hospital Munster., Mikesch JH; Department of Medicine A, University Hospital Munster., Steffen B; Medical Department II, J.-W.-Goethe University Hospital Frankfurt., Sauer T; Medical Department V, Heidelberg University Hospital., Hanoun M; Department of Hematology, Essen University Hospital., Schafer-Eckart K; Medical Department 5, University Hospital of Paracelsus Medical University Nuremberg., Krause SW; Department of Medicine 5, Uniklinikum Erlangen., Hanel M; Department for Internal Medicine III, Klinikum Chemnitz., Einsele H; Medical Department II, University Hospital Wurzburg., Jost E; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany and Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Dusseldorf (ABCD), Aachen., Brummendorf TH; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany and Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Dusseldorf (ABCD), Aachen., Scholl S; Klinik fur Innere Medizin II, Jena University Hospital, Jena., Hochhaus A; Klinik fur Innere Medizin II, Jena University Hospital, Jena., Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg., Burchert A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg., Kaufmann M; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch-Hospital Stuttgart., Niemann D; Internal Medicine, Hematology/Oncology, Palliative Medicine, Gemeinschaftsklinikum Mittelrhein, Koblenz., Schaich M; Department for Hematology, Oncology and Palliative Medicine, Rems-Murr-Klinikum, Winnenden., Blau W; Department for Internal Medicine III, Helios Dr Schmidt Hospital Wiesbaden., Kiani A; Department for Oncology and Hematology, Klinikum Bayreuth, and Comprehensive Cancer Center Erlangen-EMN., Gorner M; Department for Hematology, Oncology and Palliative Medicine, Klinikum Bielefeld, Bielefeld., Kaiser U; Medical Department II, St. Bernward Hospital, Hildesheim., Kullmer J; Medical Department II, Hematology and Oncology, DIAKO Bremen., Weber T; Department for Internal Medicine IV, University Hospital Halle (Saale)., Berdel WE; Department of Medicine A, University Hospital Munster., Ehninger G; Medical Department I, University Hospital of TU Dresden, Dresden., Muller-Tidow C; Medical Department V, Heidelberg University Hospital., Platzbecker U; Medical Department I, Hematology and Cell Therapy, University Hospital Leipzig., Serve H; Medical Department II, J.-W.-Goethe University Hospital Frankfurt., Bornhauser M; Medical Department I, University Hospital of TU Dresden, Dresden., Rollig C; Medical Department I, University Hospital of TU Dresden, Dresden., Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel., Fransecky L; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel.

Publikováno v: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2469-2477. Date of Electronic Publication: 2024 Aug 01.